Skip to content

ENTASIS THERAPEUTICS HOLDINGS INC.

CIK 0001724344

← back to feed
Revenue (TTM)
$7M
+40.0% YoY Q1 Apr 2022
Net Income (TTM)
−$50.38M
+6.6% YoY Q1 Apr 2022
EPS Diluted (TTM)
−$1.09
+48.1% YoY Q1 Apr 2022
Gross Margin
—
Q1 Apr 2022
Operating Margin
-792.9%
Q1 Apr 2022
Net Margin
-719.8%
Q1 Apr 2022
Free Cash Flow (TTM)
−$48.21M
Q1 Apr 2022
Cash
$33.55M
Q1 Apr 2022
Total Debt
—
Q1 Apr 2022
Shares Outstanding
47.85M sh
Q1 Apr 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings